Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 23 Kidney Neoplasms 10 Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Carcinoma 6 Melanoma 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Neoplasm Metastasis 3 Carcinoma, Hepatocellular 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Kidney Diseases 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Adenoid Cystic 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1

Interventions

Rituximab 93 Cyclophosphamide 72 fludarabine phosphate 53 Whole-Body Irradiation 43 Mycophenolic Acid 40 Peripheral Blood Stem Cell Transplantation 39 Bortezomib 30 Tacrolimus 29 Etoposide 29 Cyclosporine 28 Melphalan 26 Filgrastim 26 Busulfan 26 Methotrexate 24 Lenalidomide 23 Cytarabine 23 ibrutinib 20 Vincristine 20 Granulocyte Colony-Stimulating Factor 20 Antilymphocyte Serum 20 Doxorubicin 18 Bendamustine Hydrochloride 18 Dexamethasone 16 Sirolimus 14 fludarabine 13 Carmustine 13 Cord Blood Stem Cell Transplantation 12 Calcium Dobesilate 12 Radiotherapy 11 Prednisone 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lymphoma, Mantle-Cell × Axitinib × Clear all

NCT00700258 2024-09-23

STAR-TOR

Pfizer

1,520 enrolled 24 charts

Carcinoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡